Jack Geremia

Chief Executive Officer

Matterworks

Nov 2022 - Current (3 years 8 months)

Board Member

Matterworks

May 2022 - Current (4 years 2 months)

Global Head of Microbiome Discovery

DSM

Sep 2021 - Oct 2022 (1 year 2 months)

CTO & Co-Founder

Matterworks

Jan 2021 - Oct 2022 (1 year 10 months)

Founder & CSO

Midori USA Inc

Jan 2020 - Dec 2021 (2 years)

Vice-President R&D, Technology Founder

Kaleido Biosciences

Jan 2017 - Jun 2018 (1 year 6 months)

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease. The Company is also creating consumer products that optimize the microbiome's natural roles in promoting health.

VP R&D and Founder

Midori USA Inc

Apr 2016 - Dec 2019 (3 years 9 months)

A Flagship VentureLabs™ Company - Revolutionizing Animal Microbiome Health Midori is pioneering a novel category of glycan products that modulate the animal microbiome to improve health and nutrition. For the production industry, our technology improves the economics, quality, and sustainability of animal protein without resorting to widespread use of antibiotics and other drugs. For our dear companion animals, it promises better health, nutrition, and quality of life.

Founder, Technology Inventor

Cadena Bio Inc

Apr 2016 - Jan 2017 (10 months)

A Flagship VentureLabs™ Company - Human Health & Nutrition Revolutionizing human health and nutrition by nourishing the microbiome. Merged with Kaleido Biosciences in January 2017.

Technology Inventor

Kaleido Biosciences

Mar 2015 - Jan 2017 (1 year 11 months)

Invented and led development of the chemistry platform technology licensed/acquired to manipulate structure and function in microbial communities, such as the gut microbiome. Co-invented and co-developed the use and production of glycan microbiome chemistries as a novel therapeutic modality.

Founder & Head of Technology

Midori USA Inc

Jan 2013 - Mar 2016 (3 years 3 months)

Invented and led development of a novel category of glycan microbiome chemistries that modulate the functional metagenome of microbial communities, such as the microbiome.

M

Co-Founder, Head of Chemistry

Midori Renewables Inc

Dec 2009 - Dec 2014 (5 years 1 month)

Midori's Breaking the Biomass Barrier™ technology melts and digests biomass into sugars with a solid, recyclable catalyst at low-cost. This breakthrough technology overcomes the limitations of biomass conversion technologies and has already been shown to be effective on a variety of biomass feedstocks. Applications for low-cost sugar production include biofuels production and industrial chemicals fermentation feed. Midori's catalyst also converts sugars into high-value chemicals which can serve as intermediates for a range of formerly petroleum-derived substances.

Visiting Scientist, Entrepreneurial Fellow

Flagship Pioneering

May 2009 - Dec 2009 (8 months)

The Flagship VentureLabs® unit systematically originates and launches transformative companies that can shape the world’s future. Comprising a team of professional entrepreneurs with an unmatched track record of invention and company creation, Flagship VentureLabs is the first institutional platform for accelerated innovation and parallel entrepreneurship, where the processes of technology invention and company conception are merged and rapidly iterated to generate high potential new ventures.

C

Scientific Consultant, Metabolic Engineering

Codon Devices

Jul 2008 - Apr 2009 (10 months)

Invented fermentation pathways for the production of renewable six-carbon di-functional alkanes, such as adipic acid, hexamethylene diamine, and caprolactam.

Consulting Advisor

Sandia National Laboratories

Aug 2006 - Aug 2008 (2 years 1 month)

Scientific advising and contracted R&D in the areas of quantum metrology and error correction for applications relevant to national security.

Assistant Professor

The University of New Mexico

Aug 2005 - Dec 2009 (4 years 5 months)

NSF Young Investigator (CAREER) Award, Excellence in Teaching Award

Software Engineer, Chemical Informatics and Computer-Aided Drug Design

DuPont

May 1996 - Oct 1997 (1 year 6 months)

High-Throughput Screening, Library Design and Assembly, Molecular Modeling

About

Detail

Timeline

Résumé